Bing Zou

机构：Nanchang University, First Affiliated Hospital of Jiangxi Medical College, Shandong Tumor Hospital, Heilongjiang Bayi Agricultural University, Institute of Crop Sciences, Shandong First Medical University · ORCID：0000-0001-9941-4796

发表论文 157 篇 · 总被引 3443 次 · h-index 35

代表论文

• Adebrelimab plus chemotherapy and sequential thoracic radiotherapy as first-line therapy for extensive-stage small–cell lung cancer (ES-SCLC): a phase II trial (2024 · EClinicalMedicine · 被引 37)
• From pixels to patient care: deep learning-enabled pathomics signature offers precise outcome predictions for immunotherapy in esophageal squamous cell cancer (2024 · Journal of Translational Medicine · 被引 25)
• Efficacy and safety of thoracic radiotherapy in extensive-stage small-cell lung cancer patients receiving first-line immunotherapy plus chemotherapy: a propensity score matched multicentre retrospective analysis (2024 · Radiation Oncology · 被引 24)
• Tectorigenin relieved sepsis-induced myocardial ferroptosis by inhibiting the expression of Smad3 (2023 · Toxicology Research · 被引 22)
• Outcome-Supervised Deep Learning on Pathologic Whole Slide Images for Survival Prediction of Immunotherapy in Patients with Non–Small Cell Lung Cancer (2023 · Modern Pathology · 被引 16)
• Pneumonitis With Combined Immune Checkpoint Inhibitors and Chemoradiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: a Systematic Review and Meta-Analysis (2023 · Future Oncology · 被引 12)